Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN
08940-cover-synexiscxd.jpg

October 3, 2011 Cover

Volume 89, Issue 40

As big pharma exits early-stage drug development, contract research firms are serving the nonprofit and government institutions that are taking it on

Cover image:

Credit:

Full Article
Volume 89 | Issue 40

All Issues

Pharmaceuticals

Bridging The Gap

As big pharma exits early-stage drug development, contract research firms are serving the nonprofit and government institutions that are taking it on

  • Under Siege: DOE’s Loan Guarantees

    Solyndra’s bankruptcy triggers congressional investigation of Energy Department’s clean energy policies

  • Anti-HIV Trojan Horse

    Agent invites itself into the brain and then inhibits HIV enzyme

  • Adding Electrolytes

    New players follow in the footsteps of lithium-ion battery makers to meet surging U.S. demand

ADVERTISEMENT
image name
Biological Chemistry

Millipede Glow Deters Would-Be Predators

For the first time, field tests show bioluminescence can function as a warning signal

ADVERTISEMENT
ADVERTISEMENT